Pyrazolobenzazepines

An antianxiety and antidepressant pharmaceutical composition comprising an anxiolytic or antidepressively effective amount of a compound of the formulae ##EQU6## wherein Ar is unsubstituted phenyl or phenyl substituted by one or two, of the same or different substitutents selected from the group consisting of lower alkyl, lower alkoxy, halo or trifluoromethyl, Ph is 1,2-phenylene substituted by one or two halogen atoms, R.sub.o is hydrogen, lower alkyl, (hydroxy, lower alkoxy or Am)-C.sub.m H.sub.2m or AR-C.sub.n H.sub.2n, wherein Am is amino, mono- or di-lower alkylamino, lower alkyleneimino or mono-aza-, oxa- or thia-alkyleneimino, wherein the additional nitrogen, oxygen or sulfur atom is separated from the imino-nitrogen by at least 2 carbon atoms, m is an integer from 1 to 7, n such from 0 to 7, each of R.sub.1 and R.sub.2 is hydrogen or lower alkyl, and R.sub.3 is hydrogen, lower alkyl, hydroxy or lower alkanoyloxy, or a 5,6-dihydro- or 5-lower alkyl-5,6-dihydro derivative, an N-oxide of the compounds containing no hydrogen attached to nitrogen, or a lower alkanoyl, alkoxycarbonyl, AmCO, AmCS or cyano derivative of the compounds containing at least one hydrogen attached to nitrogen, or a therapeutically useful acid addition salt thereof, together with an enterally or parenterally applicable pharmaceutical excipient.